ARTIVION INC (AORT) Fundamental Analysis & Valuation

NYSE:AORT • US2289031005

38.13 USD
-0.37 (-0.96%)
Last: Mar 5, 2026, 12:29 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Forecast Earnings Financials Ownership News

This AORT fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

Fundamental Rating

4

Overall AORT gets a fundamental rating of 4 out of 10. We evaluated AORT against 184 industry peers in the Health Care Equipment & Supplies industry. AORT has only an average score on both its financial health and profitability. AORT has a decent growth rate and is not valued too expensively.


Dividend Valuation Growth Profitability Health

4

1. AORT Profitability Analysis

1.1 Basic Checks

  • In the past year AORT was profitable.
  • In the past year AORT had a positive cash flow from operations.
  • In the past 5 years AORT always reported negative net income.
  • In multiple years AORT reported negative operating cash flow during the last 5 years.
AORT Yearly Net Income VS EBIT VS OCF VS FCFAORT Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M 40M

1.2 Ratios

  • AORT has a better Return On Assets (-1.06%) than 71.74% of its industry peers.
  • AORT's Return On Equity of -2.08% is fine compared to the rest of the industry. AORT outperforms 71.74% of its industry peers.
  • Looking at the Return On Invested Capital, with a value of 2.28%, AORT is in the better half of the industry, outperforming 69.02% of the companies in the same industry.
Industry RankSector Rank
ROA -1.06%
ROE -2.08%
ROIC 2.28%
ROA(3y)-2.68%
ROA(5y)-2.4%
ROE(3y)-7.46%
ROE(5y)-6.47%
ROIC(3y)N/A
ROIC(5y)N/A
AORT Yearly ROA, ROE, ROICAORT Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 -5 -10

1.3 Margins

  • AORT has a better Operating Margin (5.26%) than 69.57% of its industry peers.
  • AORT's Operating Margin has improved in the last couple of years.
  • AORT's Gross Margin of 64.50% is fine compared to the rest of the industry. AORT outperforms 69.02% of its industry peers.
  • AORT's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 5.26%
PM (TTM) N/A
GM 64.5%
OM growth 3Y34.21%
OM growth 5Y6.88%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.05%
GM growth 5Y-0.68%
AORT Yearly Profit, Operating, Gross MarginsAORT Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 40 60

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

6

2. AORT Health Analysis

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so AORT is destroying value.
  • There is no outstanding debt for AORT. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
AORT Yearly Shares OutstandingAORT Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M
AORT Yearly Total Debt VS Total AssetsAORT Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M

2.2 Solvency

  • An Altman-Z score of 3.45 indicates that AORT is not in any danger for bankruptcy at the moment.
  • The Altman-Z score of AORT (3.45) is better than 71.20% of its industry peers.
  • The Debt to FCF ratio of AORT is 12.48, which is on the high side as it means it would take AORT, 12.48 years of fcf income to pay off all of its debts.
  • With a decent Debt to FCF ratio value of 12.48, AORT is doing good in the industry, outperforming 70.65% of the companies in the same industry.
  • AORT has a Debt/Equity ratio of 0.50. This is a healthy value indicating a solid balance between debt and equity.
  • Looking at the Debt to Equity ratio, with a value of 0.50, AORT is in line with its industry, outperforming 41.30% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.5
Debt/FCF 12.48
Altman-Z 3.45
ROIC/WACC0.22
WACC10.14%
AORT Yearly LT Debt VS Equity VS FCFAORT Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M 200M 300M

2.3 Liquidity

  • A Current Ratio of 3.93 indicates that AORT has no problem at all paying its short term obligations.
  • The Current ratio of AORT (3.93) is better than 66.30% of its industry peers.
  • AORT has a Quick Ratio of 2.88. This indicates that AORT is financially healthy and has no problem in meeting its short term obligations.
  • Looking at the Quick ratio, with a value of 2.88, AORT is in the better half of the industry, outperforming 63.59% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 3.93
Quick Ratio 2.88
AORT Yearly Current Assets VS Current LiabilitesAORT Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

4

3. AORT Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an impressive 141.86% over the past year.
  • AORT shows a decrease in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -4.78% yearly.
EPS 1Y (TTM)141.86%
EPS 3YN/A
EPS 5Y-4.78%
EPS Q2Q%112.82%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%19.2%

3.2 Future

  • The Earnings Per Share is expected to grow by 70.33% on average over the next years. This is a very strong growth
  • AORT is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 12.02% yearly.
EPS Next Y151.03%
EPS Next 2Y88.04%
EPS Next 3Y106.77%
EPS Next 5Y70.33%
Revenue Next Year11.61%
Revenue Next 2Y11.38%
Revenue Next 3Y11.73%
Revenue Next 5Y12.02%

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
AORT Yearly Revenue VS EstimatesAORT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 200M 400M 600M
AORT Yearly EPS VS EstimatesAORT Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 1 2

More info and screens

Find the best growth stocksShow best growing peers

4

4. AORT Valuation Analysis

4.1 Price/Earnings Ratio

  • A Price/Earnings ratio of 211.83 indicates a quite expensive valuation of AORT.
  • Compared to the rest of the industry, the Price/Earnings ratio of AORT indicates a somewhat cheap valuation: AORT is cheaper than 64.13% of the companies listed in the same industry.
  • The average S&P500 Price/Earnings ratio is at 27.03. AORT is valued rather expensively when compared to this.
  • With a Price/Forward Earnings ratio of 84.38, AORT can be considered very expensive at the moment.
  • 65.22% of the companies in the same industry are more expensive than AORT, based on the Price/Forward Earnings ratio.
  • The average S&P500 Price/Forward Earnings ratio is at 25.11. AORT is valued rather expensively when compared to this.
Industry RankSector Rank
PE 211.83
Fwd PE 84.38
AORT Price Earnings VS Forward Price EarningsAORT Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 50 100 150 200

4.2 Price Multiples

  • AORT's Enterprise Value to EBITDA ratio is a bit cheaper when compared to the industry. AORT is cheaper than 65.76% of the companies in the same industry.
  • 67.93% of the companies in the same industry are more expensive than AORT, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 103.21
EV/EBITDA 43.53
AORT Per share dataAORT EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6 8

4.3 Compensation for Growth

  • AORT's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
  • A more expensive valuation may be justified as AORT's earnings are expected to grow with 106.77% in the coming years.
PEG (NY)1.4
PEG (5Y)N/A
EPS Next 2Y88.04%
EPS Next 3Y106.77%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. AORT Dividend Analysis

5.1 Amount

  • No dividends for AORT!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

AORT Fundamentals: All Metrics, Ratios and Statistics

ARTIVION INC

NYSE:AORT (3/5/2026, 12:29:48 PM)

38.13

-0.37 (-0.96%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)02-12
Earnings (Next)05-04
Inst Owners87.09%
Inst Owner ChangeN/A
Ins Owners4.09%
Ins Owner Change-0.12%
Market Cap1.81B
Revenue(TTM)N/A
Net Income(TTM)-9.12M
Analysts83.08
Price Target52.46 (37.58%)
Short Float %3.2%
Short Ratio3.43
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)1085.72%
Min EPS beat(2)243.19%
Max EPS beat(2)1928.24%
EPS beat(4)3
Avg EPS beat(4)431.47%
Min EPS beat(4)-537.25%
Max EPS beat(4)1928.24%
EPS beat(8)6
Avg EPS beat(8)226.74%
EPS beat(12)8
Avg EPS beat(12)127.86%
EPS beat(16)11
Avg EPS beat(16)63.37%
Revenue beat(2)1
Avg Revenue beat(2)0.73%
Min Revenue beat(2)-1.12%
Max Revenue beat(2)2.59%
Revenue beat(4)2
Avg Revenue beat(4)-0.44%
Min Revenue beat(4)-5.37%
Max Revenue beat(4)2.59%
Revenue beat(8)4
Avg Revenue beat(8)0.31%
Revenue beat(12)7
Avg Revenue beat(12)0.63%
Revenue beat(16)10
Avg Revenue beat(16)0.6%
PT rev (1m)-0.55%
PT rev (3m)-0.55%
EPS NQ rev (1m)2.09%
EPS NQ rev (3m)-4.71%
EPS NY rev (1m)0%
EPS NY rev (3m)78.32%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0.26%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.92%
Valuation
Industry RankSector Rank
PE 211.83
Fwd PE 84.38
P/S 4.27
P/FCF 103.21
P/OCF 59.3
P/B 4.12
P/tB 64.84
EV/EBITDA 43.53
EPS(TTM)0.18
EY0.47%
EPS(NY)0.45
Fwd EY1.19%
FCF(TTM)0.37
FCFY0.97%
OCF(TTM)0.64
OCFY1.69%
SpS8.92
BVpS9.26
TBVpS0.59
PEG (NY)1.4
PEG (5Y)N/A
Graham Number6.12
Profitability
Industry RankSector Rank
ROA -1.06%
ROE -2.08%
ROCE 2.88%
ROIC 2.28%
ROICexc 2.52%
ROICexgc 6.11%
OM 5.26%
PM (TTM) N/A
GM 64.5%
FCFM 4.14%
ROA(3y)-2.68%
ROA(5y)-2.4%
ROE(3y)-7.46%
ROE(5y)-6.47%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3Y40.9%
ROICexgc growth 5Y5.66%
ROICexc growth 3Y48.24%
ROICexc growth 5Y9.09%
OM growth 3Y34.21%
OM growth 5Y6.88%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.05%
GM growth 5Y-0.68%
F-Score5
Asset Turnover0.49
Health
Industry RankSector Rank
Debt/Equity 0.5
Debt/FCF 12.48
Debt/EBITDA 4.81
Cap/Depr 56.35%
Cap/Sales 3.07%
Interest Coverage 250
Cash Conversion 67.34%
Profit Quality N/A
Current Ratio 3.93
Quick Ratio 2.88
Altman-Z 3.45
F-Score5
WACC10.14%
ROIC/WACC0.22
Cap/Depr(3y)42.06%
Cap/Depr(5y)43.23%
Cap/Sales(3y)2.8%
Cap/Sales(5y)3.13%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)141.86%
EPS 3YN/A
EPS 5Y-4.78%
EPS Q2Q%112.82%
EPS Next Y151.03%
EPS Next 2Y88.04%
EPS Next 3Y106.77%
EPS Next 5Y70.33%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%19.2%
Revenue Next Year11.61%
Revenue Next 2Y11.38%
Revenue Next 3Y11.73%
Revenue Next 5Y12.02%
EBIT growth 1Y-25.58%
EBIT growth 3Y46.49%
EBIT growth 5Y14.43%
EBIT Next Year116.09%
EBIT Next 3Y44.58%
EBIT Next 5Y34.17%
FCF growth 1Y4464.09%
FCF growth 3YN/A
FCF growth 5Y7.33%
OCF growth 1Y292.01%
OCF growth 3YN/A
OCF growth 5Y7.04%

ARTIVION INC / AORT FAQ

Can you provide the ChartMill fundamental rating for ARTIVION INC?

ChartMill assigns a fundamental rating of 4 / 10 to AORT.


What is the valuation status of ARTIVION INC (AORT) stock?

ChartMill assigns a valuation rating of 4 / 10 to ARTIVION INC (AORT). This can be considered as Fairly Valued.


Can you provide the profitability details for ARTIVION INC?

ARTIVION INC (AORT) has a profitability rating of 4 / 10.


What are the PE and PB ratios of ARTIVION INC (AORT) stock?

The Price/Earnings (PE) ratio for ARTIVION INC (AORT) is 211.83 and the Price/Book (PB) ratio is 4.12.